J. N. Patel

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Cancer pharmacogenomics is an evolving landscape and has the potential to significantly impact cancer care and precision medicine. Harnessing and understanding the genetic code of both the patient (germline) and the tumor (somatic) provides the opportunity for personalized dose and therapy selection for cancer patients. While germline DNA is useful in(More)
  • 1